Featured news

Abuja – Nigeria has introduced lenacapavir, a new long‑acting injectable medicine for HIV prevention, marking a significant step in the country’s efforts to red

Bissau—On 31 March 2026, Dr. Walter Kazadi Mulombo, Acting WHO Representative in Guinea-Bissau, met with H.E. Mr.

Nouakchott—In the Hodh El Chargui region in eastern Mauritania, where mental health services were previously limited, a listening and psychosocial support space

Maseru—For 35-year-old Mokeseng Habasisi, being the first man in Lesotho to receive Lenacapavir, a groundbreaking long-acting HIV prevention injection, was a re

Freetown—When Sierra Leone confirmed its first mpox case in January 2025, few anticipated the scale of the health emergency.

Ghana, like many countries in the WHO Africa Region, remains vulnerable to public health emergencies due to underlying vulnerabilities and chal

Nairobi- Kenya has launched its Second National Action Plan for Health Security 2026–2030, marking a significan